1955
DOI: 10.1111/j.1749-6632.1955.tb42498.x
|View full text |Cite
|
Sign up to set email alerts
|

The Role of the Adrenal Cortex in Glucose and Pyruvic Acid Metabolism in Man Including the Use of Intravenous Hydrocortisone in Acute Hypoglycemia

Abstract: l1.e EndocrineMetabolic Clinic, Albany Hospital, iilbany, N . V . I n froductionWith Thomas Addison's observations, in 1855, of the disease which now bears his name, great interest was generated in determining its cause and treatment. The synthesis of the first adrenal steroid, desoxycorticosterone, by Reichstein in 1937, with its strong electrolyte-regulating effects, prolonged the lives of Addisonians and led to a search for other compounds with which to correct the remaining metabolic disturbances character… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

1958
1958
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(5 citation statements)
references
References 75 publications
0
5
0
Order By: Relevance
“…32,33 Pyruvate-metabolizing enzymes, including pyruvate carboxylase, are also regulated by GC. 34,35 Pyruvate also may be an important mediator or marker of kidney injury, as has been reported in acute kidney injury 36 and diabetic nephropathy models. 37,38 There are therefore reasonable mechanisms by which GC treatment may regulate [pyruvate] and kidney function, and conversely where a lack of response to GC may prevent recovery of [pyruvate] and kidney function.…”
Section: Resultsmentioning
confidence: 80%
“…32,33 Pyruvate-metabolizing enzymes, including pyruvate carboxylase, are also regulated by GC. 34,35 Pyruvate also may be an important mediator or marker of kidney injury, as has been reported in acute kidney injury 36 and diabetic nephropathy models. 37,38 There are therefore reasonable mechanisms by which GC treatment may regulate [pyruvate] and kidney function, and conversely where a lack of response to GC may prevent recovery of [pyruvate] and kidney function.…”
Section: Resultsmentioning
confidence: 80%
“…In night experiments the drop in phosphate excretion after cortisol injection was small and could hardly account for a difference of l9,uequiv/min in hydrion output, nor could lack of available buffer easily explain the greater over-all increase in cation exchange observed after cortisol injection. Bartter & Fourman (1957), whose observations resembled our own, ascribed the kaliuresis after cortisol to a rise in plasma potassium concentration, due perhaps to increased tissue break-down; Knight, Kornfeld, Glaser & Bondy (1955) also found a rise of plasma potassium concentration after giving cortisol, but other workers have found the concentration to remain unchanged or to fall (Frawley, 1955;Raisz, McNeely, Saxon & Rosenbaum, 1957;Mills & Thomas, 1957). Figure 9 of Mills & Thomas (1957) includes plasma potassium concentrations for subjects M and F in the cortisol experiments here recorded, so that rising excretion and falling plasma concentration have been observed simultaneously.…”
Section: J N Mills S Thomas and K S Williamsonmentioning
confidence: 94%
“…Phosphate excretion normally falls on waking, and since cortisol and other glucocorticoids are known to lower plasma phosphate concentration (Ingbar, Kass, Burnett, Relman, Burrows, and Sisson, 1951;Frawley, 1955;Kupperman, Persky, Linsk, Isaacs, and Rosenbluth, 1955;Mills andThomas, 1957a, 1959), and hence renal excretion of phosphate, the hypothesis of a causal connexion is plausible. In many subjects the adrenal rhythm was out of phase with the sleeping habits, and the plasma steroid concentration was not high around the time of waking; we have therefore examined the data for phosphate excretion.…”
Section: Resultsmentioning
confidence: 99%